Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Midi Health vs WellMedRx

Midi Health
Graded #414

Higher grade

vs+1.8999999999999986
WellMedRx
Graded #457

Lower grade

The verdict

Midi Health takes it — 56.4/100 to 54.5/100, but only just.

Midi Health grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Midi Health is a nationwide 50-state menopause and perimenopause telehealth platform. WellMedRx is close behind and may still be the better fit — see the factor split below.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueEven
45
45
Dose & formulationEven
40
40
Clinical oversightMidi Health +5
78
73
Labs & monitoringWellMedRx +8
52
60
FulfillmentMidi Health +18
78
60
Contract termsEven
55
55
Midi Health · left barWellMedRx · right bar

The numbers

MetricMidi HealthWellMedRx
WeighScore56.4/10054.5/100
GradeCC
Scorecard rank#414#457
SemaglutideNot disclosedNot disclosed
TirzepatideNot disclosedNot disclosed
CoverageAll 50 statesCoverage not published
Brand-name accessCompounded onlyCompounded only
Oral / sublingualInjection onlyInjection only
Midi Health

Graded #414 · C

Strengths

  • Available in all 50 states
  • Accepts commercial insurance — a differentiator vs cash-pay-only GLP-1 telehealth
  • Menopause + metabolic-health focus suits women where GLP-1 efficacy and weight regulation overlap most
  • Transparent self-pay visit fees ($250 initial, $150 follow-up); GLP-1 can also be billed through commercial insurance (copay + deductible)

Where it loses points

  • Does not accept Medicare, Medicaid, or Medi-Cal
  • GLP-1 is prescribed at clinician discretion within a menopause plan, not guaranteed at intake
  • Menopause-focused — not the right fit for men or younger women whose main goal is weight loss
WellMedRx

Graded #457 · C

Strengths

  • Named licensed pharmacy partner (Mycelium Pharmacy)
  • Clinical care delivered through OpenLoop Health, an established clinician network
  • Multi-product platform — one account covers weight loss, TRT, hair, and sexual health
  • HIPAA-compliant badge on the home page

Where it loses points

  • Monthly pricing not shown until after intake
  • State coverage not disclosed — only 'a licensed professional in your state'
  • No LegitScript registration visible on the home page
  • No NABP .pharmacy seal
  • Compounded semaglutide and tirzepatide are not FDA-approved finished products

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard